{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:44:33Z","timestamp":1780933473524,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.urolonc.2022.06.015","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:12:08Z","timestamp":1658189528000},"page":"424-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Is radiotherapy helpful for the prognosis of upper urinary tract urothelial carcinoma? A meta-analysis"],"prefix":"10.1016","volume":"40","author":[{"given":"Xiao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0317-5629","authenticated-orcid":false,"given":"Guangcheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2022.06.015_bib0001","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.urolonc.2022.06.015_bib0002","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2022.06.015_bib0003","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.21037\/tau.2020.03.28","article-title":"Nomograms to predict overall and cancer-specific survival in patients with upper tract urothelial carcinoma: a large population-based study","volume":"9","author":"Qi","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.06.015_bib0004","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12957-020-01877-w","article-title":"Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma","volume":"18","author":"Li","year":"2020","journal-title":"World J Surgical Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.06.015_bib0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.06.015_bib0006","first-page":"333","article-title":"Adjuvant radiotherapy for stage III\/IV urothelial carcinoma of the upper tract","volume":"34","author":"Jwa","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2022.06.015_bib0007","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1471-2407-11-297","article-title":"Radiotherapy may improve overall survival of patients with T3\/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2022.06.015_bib0008","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ijrobp.2019.03.027","article-title":"Adjuvant treatments for advanced stage, non-metastatic upper tract urothelial carcinoma: A Multicenter Study","volume":"104","author":"Kim","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"39","key":"10.1016\/j.urolonc.2022.06.015_bib0009","doi-asserted-by":"crossref","first-page":"65983","DOI":"10.18632\/oncotarget.19623","article-title":"Prognostic factors and outcomes of primary transitional cell carcinoma of the ureter: a population-based study","volume":"8","author":"Ding","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2022.06.015_bib0010","doi-asserted-by":"crossref","first-page":"38175","DOI":"10.1038\/srep38175","article-title":"Adjuvant radiotherapy for locally advanced upper tract urothelial carcinoma","volume":"6","author":"Huang","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.urolonc.2022.06.015_bib0011","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s10147-014-0721-3","article-title":"Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma","volume":"20","author":"Sakano","year":"2015","journal-title":"Int J Clin Oncol"},{"issue":"7","key":"10.1016\/j.urolonc.2022.06.015_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048243","article-title":"Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysis","volume":"11","author":"Li","year":"2021","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.urolonc.2022.06.015_bib0013","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.21037\/tau-20-605","article-title":"Marital status impacts survival in patients with upper tract urothelial carcinoma: a population-based, propensity-matched study","volume":"9","author":"Wang","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"22","key":"10.1016\/j.urolonc.2022.06.015_bib0014","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1002\/cam4.4327","article-title":"The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma","volume":"10","author":"Zhang","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.urolonc.2022.06.015_bib0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.urolonc.2022.06.015_bib0016","first-page":"247","article-title":"Adjuvant and salvage radiotherapy for urothelial cell carcinoma of the upper urinary tract: experience in a single institution","volume":"35","author":"Fan","year":"2012","journal-title":"Chang Gung Med J"},{"issue":"1","key":"10.1016\/j.urolonc.2022.06.015_bib0017","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13014-022-02020-7","article-title":"Optimal management of recurrent and metastatic upper tract urothelial carcinoma: implications of intensity modulated radiation therapy","volume":"17","author":"Kim","year":"2022","journal-title":"Radiat Oncol (London, England)"},{"issue":"4 Pt 1","key":"10.1016\/j.urolonc.2022.06.015_bib0018","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.ju.0000137910.38441.8a","article-title":"Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter","volume":"172","author":"Czito","year":"2004","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2022.06.015_bib0019","first-page":"4051","article-title":"Effect of adjuvant radiotherapy on survival in patients with locoregional urothelial malignancies of the upper urinary tract","volume":"36","author":"Hahn","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2022.06.015_bib0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fonc.2019.00157","article-title":"Gender is a significant prognostic factor for upper tract urothelial carcinoma: a large hospital-based cancer registry study in an endemic area","volume":"9","author":"Huang","year":"2019","journal-title":"Front Oncol"},{"issue":"24","key":"10.1016\/j.urolonc.2022.06.015_bib0021","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1002\/cncr.26172","article-title":"Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study","volume":"117","author":"Vassilakopoulou","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.urolonc.2022.06.015_bib0022","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0959-8049(99)00012-X","article-title":"Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre rare cancer network study","volume":"35","author":"Ozsahin","year":"1999","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2022.06.015_bib0023","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5489\/cuaj.116","article-title":"Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in Canada","volume":"6","author":"Metcalfe","year":"2012","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"10.1016\/j.urolonc.2022.06.015_bib0024","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0090-4295(99)80346-X","article-title":"Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure","volume":"46","author":"Cozad","year":"1995","journal-title":"Urology"},{"issue":"10","key":"10.1016\/j.urolonc.2022.06.015_bib0025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.urolonc.2019.05.021","article-title":"The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: a systematic review","volume":"37","author":"Iwata","year":"2019","journal-title":"Urol Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922002344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922002344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:25:00Z","timestamp":1761042300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143922002344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1078143922002344"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.06.015","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is radiotherapy helpful for the prognosis of upper urinary tract urothelial carcinoma? A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}